Products & Services · Cost of Sales
Product — Cost of Sales
GE HealthCare Technologies Product — Cost of Sales decreased by 10.4% to $2.28B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.3%, from $1.96B to $2.28B. Over 4 years (FY 2021 to FY 2025), Product — Cost of Sales shows an upward trend with a 5.6% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ1 2021
Last reportedQ1 2026
Rolls up toTotal Cost of Revenue
How to read this metric
An increase relative to revenue suggests margin compression, while a decrease indicates improved manufacturing efficiency or lower input costs.
Detailed definition
Includes the direct costs attributable to the production and delivery of medical equipment, such as raw materials, direc...
Peer comparison
Commonly reported as Cost of Goods Sold (COGS) across the manufacturing and medtech sectors.
Metric ID:
gehc_segment_product_cost_of_salesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.80B | $1.80B | $1.80B | $1.91B | $1.92B | $2.00B | $2.15B | $2.04B | $2.08B | $2.08B | $2.27B | $1.97B | $2.05B | $2.03B | $2.23B | $1.96B | $2.16B | $2.27B | $2.55B | $2.28B |
| QoQ Change | — | +0.0% | +0.0% | +6.4% | +0.1% | +4.2% | +7.8% | -5.3% | +2.3% | -0.4% | +9.2% | -13.3% | +4.0% | -0.6% | +9.5% | -11.8% | +10.0% | +5.1% | +12.3% | -10.4% |
| YoY Change | — | — | — | — | +6.4% | +10.9% | +19.6% | +6.4% | +8.8% | +4.1% | +5.4% | -3.4% | -1.9% | -2.1% | -1.9% | -0.2% | +5.6% | +11.7% | +14.5% | +16.3% |
Range$1.80B – $2.55B
CAGR+5.1%
Avg YoY Growth+6.3%
Median YoY Growth+6.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is GE HealthCare Technologies's product — cost of sales?
- GE HealthCare Technologies (GEHC) reported product — cost of sales of $2.28B in Q1 2026.
- How has GE HealthCare Technologies's product — cost of sales changed year-over-year?
- GE HealthCare Technologies's product — cost of sales increased by 16.3% year-over-year, from $1.96B to $2.28B.
- What is the long-term trend for GE HealthCare Technologies's product — cost of sales?
- Over 4 years (2021 to 2025), GE HealthCare Technologies's product — cost of sales has grown at a 5.6% compound annual growth rate (CAGR), from $7.20B to $8.94B.
- What does product — cost of sales mean?
- The direct costs incurred to manufacture and deliver products to customers.